Literature DB >> 17565359

Transient global cerebral ischemia induces a massive increase in protein sumoylation.

Wei Yang1, Huaxin Sheng, David S Warner, Wulf Paschen.   

Abstract

A new group of proteins, small ubiquitin-like modifier (SUMO) proteins, has recently been identified and protein sumoylation has been shown to play a major role in various signal transduction pathways. Here, we report that transient global cerebral ischemia induces a marked increase in protein sumoylation. Mice were subjected to 10 mins severe forebrain ischemia followed by 3 or 6 h of reperfusion. Transient cerebral ischemia induced a massive increase in protein sumoylation by SUMO2/3 both in the hippocampus and cerebral cortex. SUMO2/3 conjugation was associated with a decrease in levels of free SUMO2/3. After ischemia, protein levels of the SUMO-conjugating enzyme Ubc9 were transiently decreased in the cortex but not in the hippocampus. We also exposed HT22 cells to arsenite, a respiratory poison that impairs cytoplasmic function and induces oxidative stress. Arsenite exposure induced a marked rise in protein sumoylation, implying that impairment of cytoplasmic function and oxidative stress may be involved in the massive post-ischemic activation of SUMO conjugation described here. Sumoylation of transcription factors has been shown to block their activation, with some exceptions such as the heat-shock factor and the hypoxia-responsive factor, where sumoylation blocks their degradation, and the nuclear factor-kappaB (NF-kappaB) essential modulator where sumoylation leads to an activation of NF-kappaB. Because protein sumoylation is known to be involved in the regulation of various biologic processes, the massive post-ischemic increase in protein sumoylation may play a critical role in defining the final outcome of neurons exposed to transient ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565359     DOI: 10.1038/sj.jcbfm.9600523

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  72 in total

Review 1.  Ubiquitin-proteasome system as a modulator of cell fate.

Authors:  Simon J Thompson; Liam T Loftus; Michelle D Ashley; Robert Meller
Journal:  Curr Opin Pharmacol       Date:  2007-11-05       Impact factor: 5.547

2.  Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification.

Authors:  Jianmei Zhu; Shanshan Zhu; Catherine M Guzzo; Nathan A Ellis; Ki Sa Sung; Cheol Yong Choi; Michael J Matunis
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

Review 3.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.

Authors:  Wei Yang; Huaxin Sheng; J Will Thompson; Shengli Zhao; Liangli Wang; Pei Miao; Xiaozhi Liu; M Arthur Moseley; Wulf Paschen
Journal:  Stroke       Date:  2014-02-25       Impact factor: 7.914

5.  SUMO2/3 is associated with ubiquitinated protein aggregates in the mouse neocortex after middle cerebral artery occlusion.

Authors:  Karin Hochrainer; Katherine Jackman; Corinne Benakis; Josef Anrather; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-29       Impact factor: 6.200

6.  Selective antegrade cerebral perfusion reduces brain injury following deep hypothermic circulatory arrest in the piglets' model by decreasing the levels of protein SUMO2/3-ylation.

Authors:  Bin Li; Yaobin Zhu; Aijun Liu; Wei Lu; Junwu Su; Jing Zhang; Zhiqiang Li; Xiangming Fan; Yinglong Liu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

7.  Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.

Authors:  Georgia Chachami; Nicolas Stankovic-Valentin; Angeliki Karagiota; Angeliki Basagianni; Uwe Plessmann; Henning Urlaub; Frauke Melchior; George Simos
Journal:  Mol Cell Proteomics       Date:  2019-03-29       Impact factor: 5.911

8.  Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Authors:  Sahra Bodo; Cécile Campagne; Tin Htwe Thin; Daniel S Higginson; H Alberto Vargas; Guoqiang Hua; John D Fuller; Ellen Ackerstaff; James Russell; Zhigang Zhang; Stefan Klingler; HyungJoon Cho; Matthew G Kaag; Yousef Mazaheri; Andreas Rimner; Katia Manova-Todorova; Boris Epel; Joan Zatcky; Cristian R Cleary; Shyam S Rao; Yoshiya Yamada; Michael J Zelefsky; Howard J Halpern; Jason A Koutcher; Carlos Cordon-Cardo; Carlo Greco; Adriana Haimovitz-Friedman; Evis Sala; Simon N Powell; Richard Kolesnick; Zvi Fuks
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

9.  Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats.

Authors:  Hiroshi Yao; Tatsuo Nakahara; Nobuaki Nakagawa; Kijiro Hashimoto; Toshihide Kuroki
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

10.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.